iShares Neuroscience and HeaIBRNETF
13F holders, Q2 2025 (June 30)4holders
1new positions
1sold out
$21.91avg. 13F price*
At the end of Q2 2025, 4 institutions reported holding iShares Neuroscience and Hea (IBRN) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 1 sold out. The largest holders were BlackRock, Inc. ($2.1M), Principal Securities, Inc. ($16K) and Cwm, LLC ($4K).
- Company
- iShares Neuroscience and Hea
- CUSIP
- 46436E353
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2K |
| Exits | 1 | $260K |
All 13F filers, Q1 2025 → Q2 2025: 85 shares bought and 20,615 shares sold, net −20,530 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| BlackRock, Inc. | 0.00% | Reduce -8.7% | 94,000 | $2.1M |
| Principal Securities, Inc. | 0.00% | No change | 732 | $16K |
| Cwm, LLC | 0.00% | No change | 163 | $4K |
| UBS Group AG | 0.00% | New | 85 | $2K |
"% of holder's portfolio" is IBRN's weight in each manager's 13F, not the share of iShares Neuroscience and Hea the manager owns.